PATENT CLAIM ANALYSIS

Application Number: 15911797
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-07
Patent Classification: ["514", "316000"]

Abstract:
The invention relates to activators of soluble guanylate cyclase and their use in pharmaceutical compositions, primarily topically administered ophthalmic compositions. The pharmaceutical compositions are useful for reducing intraocular pressure in animals of the mammalian species.

Claim (Index 1):
A pharmaceutical composition comprising a compound, or a pharmaceutically acceptable salt thereof, which is 1-(6-(3,5-difluoro-2-((4-methyl-6-(1-(2,2,2-trifluoroethyl)piperid in-4-yl)pyridin-3-yl)methoxy)phenyl)pyridin-2-yl) piperidine-4-carboxylic acid, 1-(6-(3,5-difluoro-2-((2-methyl-4-(1-(tetrahydrofuran-3-carbonyl)piperidin-4-yl)benzyl)oxy)phenyl)pyridin-2-yl)piperidine-4-carboxylic acid, or 1-(6-(3,5-difluoro-2-((2-methyl-4-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)benzyl)oxy)phenyl)pyridin-2-yl)piperidine-4-carboxylic acid, and one or more pharmaceutically acceptable excipients.

Metadata:
- Claim Count in Document: 13.0
- Percentile: 90.0
- Lexical Diversity: 1.22581
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15509895', '15320810', '16063059', '15320815', '12711854']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7637384821300381
- 35 USC 102 Novelty (BERT): 0.6241218367566493
- Combined Prediction Score: 0.7497768175926993
- Mean Citation Score: 411.9334
- Max Citation Score: 555.7074
- Similarity Product: 532.7858662048101

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test